2010
DOI: 10.1186/1471-230x-10-17
|View full text |Cite
|
Sign up to set email alerts
|

Carcinoid tumor of the minor papilla in complete pancreas divisum presenting as recurrent abdominal pain

Abstract: BackgroundTumors of the minor papilla of the duodenum are extremely rare, and they are mostly neuroendocrine tumors, such as somatostatinomas and carcinoid tumors. However, true incidence of carcinoid tumors in minor papilla might be much higher, because patients with minor papillary tumors usually remain asymptomatic. We report a very unusual case of carcinoid tumor in a patient with complete pancreas divisum with a review of the literature.Case presentationA 56-year-old female patient was referred for evalua… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 20 publications
0
5
0
Order By: Relevance
“…Contrary to the increasing number of GEP-NETs, GEP-NETs of the accessory papilla of the duodenum are very rare. The characteristics in reported cases of GEP-NETs of the accessory papilla of the duodenum are demonstrated in Table 1 [3][4][5][6][7][8][9][10][11]. The average tumor size was approximately 11 mm.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Contrary to the increasing number of GEP-NETs, GEP-NETs of the accessory papilla of the duodenum are very rare. The characteristics in reported cases of GEP-NETs of the accessory papilla of the duodenum are demonstrated in Table 1 [3][4][5][6][7][8][9][10][11]. The average tumor size was approximately 11 mm.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, GEP-NETs of the accessory papilla of the duodenum are extremely rare. To date, there have been only nine cases of GEP-NETs of the accessory papilla of the duodenum reported in the English literature [3][4][5][6][7][8][9][10][11]. We hereby present a case of GEP-NET of the accessory papilla of the duodenum successfully treated with robotic pancreatoduodenectomy.…”
Section: Introductionmentioning
confidence: 99%
“…Over 200 cases of pancreatic carcinoids have most likely been reported as of today; the following ensues from a literature review (Table I) (16): a) pancreatic carcinoid or serotoninoma secretes and releases sero-tonin (5-HIAA in urine), since it is made up of EC cells (argyrophilia) within the pancreas, with positive immunohistochemistry for said hormone; b) tumors are malignant in about 70% of cases, and present with either typical or atypical CS (fewer than 50%) as well as a triad of abdominal pain, diarrhea, and weight loss; c) survival at 5 years is low, around 30%, but may respond to somatostatin analogs and radical surgery; d) frequency is around 1% of all carcinoids, and 10-year survival is 10% (35) because of high malignant potential (36); e) they may be associated with MHS, MEN-1 (9), and gastroduodenal carcinoids (37); and f) in contrast to pancreatic carcinoids, carcinoids in the common bile duct and minor papilla are extremely rare (8 cases reported), and those of the papilla are rare (70 cases reported) (38).…”
Section: Discussionmentioning
confidence: 99%
“…The anomaly is caused by absent or incomplete fusion of the ventral (main or Wirsung) and dorsal (marginal or Santorini) ducts (Kanth et al, 2014) and results in coexistence of two ampullary systems: the ventral duct drains the pancreatic head through the major ampulla, while the dorsal duct drains the pancreatic body and tail through the minor ampulla (Ferri et al, 2019). Ampullary neoplasms are rare, comprising 7% of all periampullary malignancies (Adsay et al, 2012), and association of theses tumors with pancreas divisum is considered an episodic event (Singh et al, 2003;Outtas et al, 2004;Kim et al, 2010). Their occurrence has been reported in families with hereditary cancer syndromes, such as Familial Adenomatous Polyposis (Pérez-Cuadrado-Robles et al, 2019) and Neurofibromatosis type 1 (NF1) (Tewari et al, 2014).…”
Section: Introductionmentioning
confidence: 99%